Anika Therapeutics, Inc. (ANIK) Tops Q2 EPS by 3c, Revenue Light
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.51 -2.36%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
